• Home
• Mailbox
• Boards
• Favorites
• Whats Hot!
• Login - Join Now!

Search Search Type Board Post Member

Profile

About Latest Posts Latest Blog Posts Boards Posted On Boards Moderating

sillylung's Profile

Avatar:

Membership:

Premium

Person Marks:

3

Total Posts:

99

Total Blog Posts:

0

Total Compensated Posts:

0

Moderating:

0

Alias Born

07/09/2014 10:16:08 PM

Personal info

Recent Articles

• Celebrating Melanie Barraza: A Leader in Community Engagement
• Salesforce and Accenture: A Focused Investment Analysis
• Celebrating 75 Years of Formula 1 at Pebble Beach
• Heron Therapeutics Prepares for Q2 2025 Financial Disclosure
• Heron Therapeutics Set to Share Q2 2025 Results Soon
• Monster Army's Dominance at the Pro Downhill Series Thrills Fans
• New Frontier Aerospace Selected for Innovative Spacecraft Project
• Transforming Sustainability into Revenue: A Strategic Guide
• Grupo Elektra Showcases Promising Financial Growth in Q2
• Discover Innovative MICE Solutions at Pullman Danang Resort
• New Frontier Aerospace Chosen for Innovative Space Project
• Analyzing the Recent US-China Trade Talks and Their Implications
• Exploring AI Innovations from Runway and Impact on Entertainment
• Key Updates on Class Actions Involving Neogen and Others
• Allegiant Expands Network with Exciting New Nonstop Flights
• Investors Target Hims & Hers and Sarepta Through Legal Action
• Hercules Metals Secures $15 Million Financing for Growth
• Argo Blockchain Faces Nasdaq Delisting, Seeks Hearing
• Transforming $100 into Significant Returns with Microsoft Stock
• Pacific Valley Bancorp Sees Growth Despite Challenges
• Understanding Legal Actions Against Flywire Corporation's Management
• Pacific Valley Bancorp's Q2 2025 Financial Performance Insights
• STIHL TIMBERSPORTS® Championship Showcases New Records and Stars
• Market Dynamics: Understanding the Impact of the Dollar Surge
• QCI's Rebirth: Embracing Innovators and Casino Technology
• Unlocking Competitiveness in Wind and Solar Energy Futures
• Apellis Pharmaceuticals Receives FDA Approval for EMPAVELI®
• Understanding Recent Developments in Flywire Corporation's Legal Affairs
• Current Job Market Woes for Graduates: Navigating Challenges Ahead
• Reckitt Benckiser Faces Class Action Lawsuit Over Infant Formula Safety
• Legal Actions To Safeguard Investor Interests in Tempus & Vestis
• Investing in argenx: A 5-Year Journey of Growth and Value
• Top Stocks Increasing Buybacks after Strong Earnings Performance
• Unlocking America's Technological Future: Key Resources Revealed
• North Park University Nursing Student Achieves Key Fellowship
• Mary Kay’s New Electric Cadillac: A Bold Step Forward
• Elevate Your Muscle Growth: The Power of CrazyBulk Supplements
• How a $1000 Investment in Parker Hannifin Thrived Over Time
• Understanding the Investor Avenues with Sarepta Therapeutics
• Innovative Report Highlights Renewable Energy's Viability
• The Transformative Power of Investing: A 15-Year Journey With NSIT
• UnitedHealth Group Faces Class Action as Lawsuit is Filed
• Court Ruling Challenges SEC's Funding of Data Collection Schemes
• Class Action Lawsuits Highlight Pressures on Bitfarms and Reddit
• Why Regional Health Properties Shareholders Should Embrace Merger
• Sable Offshore Corp. Class Action Lawsuit: Investor Alert
• Investigation Launched into Allianz Life Insurance Data Breach
• Discovering the Growth of Sprouts Farmers Market Stock Over a Decade
• Lowe's CEO Emphasizes Job Security through Skilled Trades
• Invesque Inc. Transitions Management and Sells 11 Assets